MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1160/th16-02-0102

Медицинская библиотека · Thrombosis and haemostasis · 2016

Morphine delays the onset of action of prasugrel in patients with prior history of ST-elevation myocardial infarction.

Thomas Mark R, Morton Allison C, Hossain Rashed, Chen Beining, Luo Lei, Shahari Nur Nazihah B Md, Hua Peng, Beniston Richard G, Judge Heather M, Storey Robert F

СтатьяРандомизированное исследованиеПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

Delays in the onset of action of prasugrel during primary percutaneous coronary intervention (PPCI) have been reported and could be related to the effects of morphine on gastric emptying and subsequent intestinal absorption. The study objective was to determine whether morphine delays the onset of action of prasugrel in patients with a prior history of ST-elevation myocardial infarction (STEMI) treated with PPCI. This was a crossover study of 11 aspirin-treated patients with prior history of STEMI treated with PPCI, for which prasugrel and morphine had been previously administered. Patients were randomised to receive either morphine (5 mg) or saline intravenously followed by 60 mg prasugrel. Blood samples were collected before randomised treatment and over 24 hours after prasugrel administration. The inhibitory effects of prasugrel on platelets were determined using the VerifyNow P2Y12 assay and light transmission aggregometry. Plasma levels of prasugrel and prasugrel active metabolite were measured. Platelet reactivity determined by VerifyNow PRU, VerifyNow % Inhibition and LTA was significantly higher at 30-120 minutes (min) when morphine had been co-administered compared to when saline had been co-administered. Morphine, compared to saline, significantly delayed adequate platelet inhibition after prasugrel administration (158 vs 68 min; p = 0.006). Patients with delayed onset of platelet inhibition also had evidence of delayed absorption of prasugrel. In conclusion, prior administration of intravenous morphine significantly delays the onset of action of prasugrel. Intravenous drugs may be necessary to reduce the risk of acute stent thrombosis in morphine-treated STEMI patients undergoing PPCI.

Для цитирования: Thomas Mark R, Morton Allison C, Hossain Rashed, Chen Beining, Luo Lei, Shahari Nur Nazihah B Md, Hua Peng, Beniston Richard G, Judge Heather M, Storey Robert F. Morphine delays the onset of action of prasugrel in patients with prior history of ST-elevation myocardial infarction.. Thrombosis and haemostasis. 2016. DOI: 10.1160/th16-02-0102.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.